Commercializing Industrial Biotechnology is a workshop where industrial biotech thought leaders share their experiences and their views on current challenges.
At this event in collaboration with Synbiobeta, we will bring together leaders in the field of synthetic biology to discuss how we can re-imagine R+D, digitalization, and manufacturing.
Riffyn CEO, Tim Gardner, joined an expert panel hosted by JMP on 23 June to discuss the profound impact of DoE on scientific discovery. Watch the recording.
Timothy Gardner will lead a breakout discussion on creating a digital backbone for biomanufacturing as part of the SynBioBeta Built with Biology Summit.
The number one asset of any R&D company is its data — if it's meaningful and trustworthy. Tim Gardner discusses creating and harnessing data with Riffyn Nexus & JMP. Watch recording here.